Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025)
Outlook Therapeutics (OTLK) posted quarterly EBIT Margin of 18863.9% for Q3 2025, up 1903.09% quarter-over-quarter from 1046.2% in Q2 2025.
Outlook Therapeutics (OTLK) EBIT Margin (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has reported EBIT Margin for 6 consecutive years, with 18863.9% the latest figure, recorded in Q3 2025.
- In Q3 2025, EBIT Margin changed N/A year-over-year to 18863.9%; the TTM figure through Sep 2025 stood at 854.19% (changed N/A YoY), while the FY2025 annual figure was 4744.25%, changed N/A from the prior year.
- EBIT Margin grew to 18863.9% in Q3 2025 per OTLK's latest filing, from 1046.2% in the prior quarter.
- Across five years, EBIT Margin topped out at 18863.9% in Q3 2025 and bottomed at 1046.2% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Outlook Therapeutics | 93.64 Mn | 82.40 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18,863.90% |
| Jun 30, 2025 | -1,046.20% |
| Sep 30, 2019 | -216.83% |
| Jun 30, 2019 | -966.72% |
| Mar 31, 2019 | -1,201.86% |
| Dec 31, 2018 | -960.78% |
| Sep 30, 2018 | -1,608.21% |
| Jun 30, 2018 | -935.35% |
| Mar 31, 2018 | -884.97% |
| Dec 31, 2017 | -411.95% |
| Sep 30, 2017 | -100.29% |
| Jun 30, 2017 | -2,420.14% |
| Mar 31, 2017 | -2,585.60% |
| Dec 31, 2016 | -5,870.30% |
| Sep 30, 2016 | -2,011.04% |
| Jun 30, 2016 | -4,450.95% |
| Mar 31, 2016 | -296.91% |
| Dec 31, 2015 | -1,649.75% |
| Sep 30, 2015 | -3,510.23% |
| Jun 30, 2015 | -853.02% |